Ken Chen

99.6k total citations · 5 hit papers
306 papers, 11.1k citations indexed

About

Ken Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ken Chen has authored 306 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 64 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Ken Chen's work include Cancer Genomics and Diagnostics (56 papers), Single-cell and spatial transcriptomics (30 papers) and Genomics and Phylogenetic Studies (19 papers). Ken Chen is often cited by papers focused on Cancer Genomics and Diagnostics (56 papers), Single-cell and spatial transcriptomics (30 papers) and Genomics and Phylogenetic Studies (19 papers). Ken Chen collaborates with scholars based in United States, China and France. Ken Chen's co-authors include Li Ding, David E. Larson, Richard K. Wilson, Elaine R. Mardis, Michael D. McLellan, Nicholas E. Navin, Daniel C. Koboldt, Nicole Schreiber‐Agus, Ronald A. DePinho and Carlos Cordon‐Cardo and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ken Chen

288 papers receiving 10.9k citations

Hit Papers

The Ink4a Tumor Suppresso... 1998 2026 2007 2016 1998 2009 2009 2014 2021 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ken Chen 6.0k 2.9k 2.5k 1.9k 872 306 11.1k
Zhongming Zhao 9.1k 1.5× 3.1k 1.1× 1.3k 0.5× 3.1k 1.6× 1.0k 1.2× 535 15.1k
Jane Fridlyand 6.7k 1.1× 2.0k 0.7× 3.5k 1.4× 1.4k 0.7× 717 0.8× 68 10.6k
Markus Ringnér 7.5k 1.2× 3.1k 1.1× 3.0k 1.2× 1.5k 0.8× 1.1k 1.3× 96 12.2k
Eivind Hovig 6.0k 1.0× 2.3k 0.8× 2.2k 0.9× 1.1k 0.6× 685 0.8× 218 8.9k
Lodewyk F.A. Wessels 10.2k 1.7× 4.3k 1.5× 4.6k 1.8× 2.1k 1.1× 1.3k 1.5× 252 15.8k
Manfred Schwab 8.1k 1.4× 2.9k 1.0× 2.5k 1.0× 2.2k 1.2× 544 0.6× 150 12.4k
Satoru Miyano 10.5k 1.7× 2.7k 0.9× 1.3k 0.5× 1.3k 0.7× 1.1k 1.3× 523 15.5k
Jean Yang 8.2k 1.4× 1.6k 0.5× 1.4k 0.6× 1.2k 0.6× 1.6k 1.8× 257 13.8k
Quaid Morris 13.3k 2.2× 3.6k 1.3× 1.2k 0.5× 1.8k 0.9× 1.2k 1.3× 158 17.3k
Javed Khan 6.2k 1.0× 2.0k 0.7× 2.2k 0.9× 905 0.5× 946 1.1× 350 10.9k

Countries citing papers authored by Ken Chen

Since Specialization
Citations

This map shows the geographic impact of Ken Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Chen more than expected).

Fields of papers citing papers by Ken Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Chen. The network helps show where Ken Chen may publish in the future.

Co-authorship network of co-authors of Ken Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Chen. A scholar is included among the top collaborators of Ken Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Chen. Ken Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Min, Hao Liu, Lan Li, et al.. (2024). Absorbed Bioactive Compounds Replicate Guanxin II-Induced Endothelium-Associated in/ex vivo Vasodilation. Chinese Journal of Integrative Medicine. 30(5). 387–397. 3 indexed citations
2.
3.
Goldberg, Jonathan, Jennifer L. Guerriero, Anne V. Philips, et al.. (2024). Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer. Cancer Research Communications. 4(2). 496–504. 7 indexed citations
5.
Zhang, Jiwen, et al.. (2024). Local connection reinforcement learning method for efficient robotic peg-in-hole assembly. Engineering Applications of Artificial Intelligence. 133. 108520–108520. 4 indexed citations
7.
Fan, Huihui, Feng Wang, Andy G.X. Zeng, et al.. (2023). Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. Communications Biology. 6(1). 765–765. 11 indexed citations
8.
Johnson, Amber M., Patrick Kwok‐Shing Ng, Michael Kahle, et al.. (2023). Actionability classification of variants of unknown significance correlates with functional effect. npj Precision Oncology. 7(1). 67–67. 6 indexed citations
9.
Hill, Holly A., Preetesh Jain, Chi Young Ok, et al.. (2023). Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma. Cancer Research Communications. 3(8). 1435–1446. 3 indexed citations
10.
Wang, Bing, et al.. (2023). Robotic assembly control reconfiguration based on transfer reinforcement learning for objects with different geometric features. Engineering Applications of Artificial Intelligence. 129. 107576–107576. 1 indexed citations
11.
Monberg, Maria E., Heather Geiger, Jaewon J. Lee, et al.. (2022). Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Nature Communications. 13(1). 17 indexed citations
12.
Ban, Yixuan, et al.. (2022). RAM360: Robust Adaptive Multi-Layer 360$^\circ$ Video Streaming With Lyapunov Optimization. IEEE Transactions on Multimedia. 25. 4225–4239. 13 indexed citations
13.
Thompson, Philip A., Xianli Jiang, Pinaki P. Banerjee, et al.. (2022). A phase two study of high dose blinatumomab in Richter’s syndrome. Leukemia. 36(9). 2228–2232. 20 indexed citations
14.
Akçakanat, Argun, Xiaofeng Zheng, Tae‐Beom Kim, et al.. (2021). Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer. Clinical Cancer Research. 27(11). 3243–3252. 17 indexed citations
15.
Huang, Kuan‐lin, Adam Scott, Daniel Cui Zhou, et al.. (2021). Spatially interacting phosphorylation sites and mutations in cancer. Nature Communications. 12(1). 2313–2313. 13 indexed citations
16.
Zheng, Siyuan, Kristin Alfaro-Munoz, Wei Wei, et al.. (2019). Prospective Clinical Sequencing of Adult Glioma. Molecular Cancer Therapeutics. 18(5). 991–1000. 15 indexed citations
17.
Evans, Kurt W., Erkan Yuca, Argun Akçakanat, et al.. (2017). A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors. Clinical Cancer Research. 23(21). 6468–6477. 48 indexed citations
18.
Morris, Van K., Xiayu Rao, Curtis R. Pickering, et al.. (2017). Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal. Molecular Cancer Research. 15(11). 1542–1550. 50 indexed citations
19.
Dogruluk, Turgut, Yiu Huen Tsang, Fengju Chen, et al.. (2015). Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations. Cancer Research. 75(24). 5341–5354. 118 indexed citations
20.
Chen, Ken & Laurent Decreusefond. (1996). An approximate analysis of waiting time in multi-class M/G /1/./ EDF queues. 190–199. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026